Evidence map›Paper›PMID 37131096›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2023

Personalized diagnosis in suspected myocardial infarction.

Johannes Tobias Neumann, Raphael Twerenbold, Francisco Ojeda, Sally J Aldous, Brandon R Allen, Fred S Apple, Hugo Babel, Robert H Christenson, Louise Cullen, Eleonora Di Carluccio and 28 more

9 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 9 registered trials, which are not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01852123 nacompletednot on this map

High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of EdinburghRan2013 to 2017Enrolled48,282ConditionsAcute Coronary Syndrome, Myocardial InfarctionArmsHigh-sensitivity troponin I assay
NCT01994577 completednot on this map

Determining the Optimum Treatment Cutoffs for Cardiac Troponin Assays in Patients Presenting to the Emergency Department With Suspected Cardiac Ischemia

TypeobservationalSponsorCanadian Institutes of Health Research (CIHR)Ran2013 to 2017Enrolled100ConditionsAcute Coronary Syndrome (ACS)
NCT02060760 completednot on this map

Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes

Typeobservational_patient_registrySponsorHennepin Healthcare Research InstituteRan2014 to 2021Enrolled1,927ConditionsAcute Coronary Syndrome, Myocardial Infarction, Troponin
NCT02355457 recruitingnot on this map

Biomarkers in Acute Cardiac Care

Typeobservational_patient_registrySponsorUniversitätsklinikum Hamburg-EppendorfRan2013 to 2027Enrolled5,000ConditionsAcute Coronary Syndrome, Myocardial Infarction, Chest Pain
NCT02984436 completednot on this map

High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification

TypeobservationalSponsorUniversity of FloridaRan2017 to 2020Enrolled1,572ConditionsAcute Coronary Syndrome, Chest PainArmsBlood Sample, HEART Score
NCT03111862 completednot on this map

Observational Study on the Safety of Accelerated Rule-out Protocols in Patients Admitted With Chest Pain to a Crowded CPU

Typeobservational_patient_registrySponsorUniversity Hospital HeidelbergRan2017 to 2018Enrolled3,567ConditionsAcute Coronary Syndrome, NSTEMI - Non-ST Segment Elevation MIArmsNSTEMI Rule-Out according to hs-TnT
NCT03227159 completednot on this map

Study for Evaluation of Newly Onset Chest Pain and Rapid Diagnosis of Myocardial Necrosis (stenoCARDIA)

TypeobservationalSponsorUniversitätsklinikum Hamburg-EppendorfRan2007 to 2008Enrolled1,818ConditionsAcute Myocardial Infarction
NCT04772157 completednot on this map

Evaluation of the Siemens POC HS CTn-I Test System

TypeobservationalSponsorHennepin Healthcare Research InstituteRan2020 to 2024Enrolled1,000ConditionsAcute Myocardial Infarction, Acute Coronary SyndromeArmsCardiac Troponin Testing
NCT05484544 completednot on this map

Safety and Efficacy of Hs-cTnT Protocols

TypeobservationalSponsorRegion SkaneRan2013 to 2014Enrolled1,167ConditionsChest Pain, DiagnosisArmsHigh sensitivity troponin T
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Observational
  2. Diagnostic validation of a novel high-sensitivity cardiac troponin T assay.European heart journal. Acute cardiovascular care · 2026
    Article
  3. Article
  4. High-sensitivity cardiac troponin assays at the point of care.Clinical chemistry and laboratory medicine · 2026
    Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. How to Approach Patients with Acute Chest Pain.Reviews in cardiovascular medicine · 2024
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 19 institutions in 9 countries.

Johannes Tobias Neumann *Department of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.ORCID http://orcid.org/0000-0002-9478-2757
Raphael Twerenbold *Department of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.ORCID http://orcid.org/0000-0003-3814-6542
Francisco OjedaDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Sally J AldousDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Brandon R AllenDepartment of Emergency Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Fred S AppleDepartments of Laboratory Medicine and Pathology, Hennepin Healthcare/HCMC and University of Minnesota, Minneapolis, MN, USA.
Hugo BabelCardio-CARE, Medizincampus Davos, Davos, Switzerland.
Robert H ChristensonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
Louise CullenDepartment of Emergency Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Eleonora Di CarluccioCardio-CARE, Medizincampus Davos, Davos, Switzerland.
Dimitrios DoudesisBHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Ulf EkelundDepartment of Internal and Emergency Medicine, Lund University, Skåne University Hospital, Lund, Sweden.
Evangelos GiannitsisDepartment of Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
Jaimi GreensladeDepartment of Emergency Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Kenji InoueJuntendo University Nerima Hospital, Tokyo, Japan.
Tomas JernbergDepartment of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.
Peter KavsakDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Till KellerDepartment of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
Kuan Ken LeeBHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Bertil LindahlDepartment of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Thiess LorenzDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Simon A MahlerDepartment of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Nicholas L MillsBHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Arash MokhtariDepartment of Internal Medicine and Emergency Medicine and Department of Cardiology, Lund University, Skåne University Hospital, Lund, Sweden.
William ParsonageAustralian Centre for Health Service Innovation, Queensland University of Technology, Kelvin Grove, Australia.
John W PickeringDepartment of Medicine, Christchurch and Emergency Department, University of Otago, Christchurch Hospital, Christchurch, New Zealand.
Christopher J PembertonDepartment of Medicine, Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
Christoph ReichDepartment of Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
A Mark RichardsDepartment of Medicine, Christchurch and Emergency Department, University of Otago, Christchurch Hospital, Christchurch, New Zealand.
Yader SandovalMinneapolis Heart Institute, Abbott Northwestern Hospital, and Minneapolis Heart Institute Foundation, Minneapolis, MN, USA.
Martin P ThanDepartment of Medicine, Christchurch and Emergency Department, University of Otago, Christchurch Hospital, Christchurch, New Zealand.
Betül ToprakDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Richard W TroughtonDepartment of Medicine, Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
Andrew WorsterDivision of Emergency Medicine, McMaster University, Hamilton, ON, Canada.
Tanja ZellerDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Andreas Ziegler *Cardio-CARE, Medizincampus Davos, Davos, Switzerland.
Stefan Blankenberg *Department of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. s.blankenberg@uke.de.
ARTEMIS study group
Universität Hamburg · DEChristchurch Hospital · NZMcMaster University · CAUniversity of Edinburgh · GBUniversity of Otago · NZHeidelberg University · DELund University · SERoyal Brisbane and Women's Hospital · AUAbbott Northwestern Hospital · USJuntendo University Nerima Hospital · JPKarolinska University Hospital · SEKerckhoff Klinik · DEQueensland University of Technology · AUUniversity of Florida · USUniversity of KwaZulu-Natal · ZAUniversity of Maryland, Baltimore · USUniversity of Minnesota · USUppsala University · SEWake Forest University · US

Funding

British Heart Foundation FS/18/25/33454British Heart Foundation RG/20/10/34966
6 · The paper itself

Abstract

backgroundIn suspected myocardial infarction (MI), guidelines recommend using high-sensitivity cardiac troponin (hs-cTn)-based approaches. These require fixed assay-specific thresholds and timepoints, without directly integrating clinical information. Using machine-learning techniques including hs-cTn and clinical routine variables, we aimed to build a digital tool to directly estimate the individual probability of MI, allowing for numerous hs-cTn assays.

methodsIn 2,575 patients presenting to the emergency department with suspected MI, two ensembles of machine-learning models using single or serial concentrations of six different hs-cTn assays were derived to estimate the individual MI probability (ARTEMIS model). Discriminative performance of the models was assessed using area under the receiver operating characteristic curve (AUC) and logLoss. Model performance was validated in an external cohort with 1688 patients and tested for global generalizability in 13 international cohorts with 23,411 patients.

resultsEleven routinely available variables including age, sex, cardiovascular risk factors, electrocardiography, and hs-cTn were included in the ARTEMIS models. In the validation and generalization cohorts, excellent discriminative performance was confirmed, superior to hs-cTn only. For the serial hs-cTn measurement model, AUC ranged from 0.92 to 0.98. Good calibration was observed. Using a single hs-cTn measurement, the ARTEMIS model allowed direct rule-out of MI with very high and similar safety but up to tripled efficiency compared to the guideline-recommended strategy.

conclusionWe developed and validated diagnostic models to accurately estimate the individual probability of MI, which allow for variable hs-cTn use and flexible timing of resampling. Their digital application may provide rapid, safe and efficient personalized patient care. TRIAL REGISTRATION NUMBERS: Data of following cohorts were used for this project: BACC ( www. CLINICALTRIALS: gov ; NCT02355457), stenoCardia ( www. CLINICALTRIALS: gov ; NCT03227159), ADAPT-BSN ( www.australianclinicaltrials.gov.au ; ACTRN12611001069943), IMPACT ( www.australianclinicaltrials.gov.au , ACTRN12611000206921), ADAPT-RCT ( www.anzctr.org.au ; ANZCTR12610000766011), EDACS-RCT ( www.anzctr.org.au ; ANZCTR12613000745741); DROP-ACS ( https://www.umin.ac.jp , UMIN000030668); High-STEACS ( www. CLINICALTRIALS: gov ; NCT01852123), LUND ( www. CLINICALTRIALS: gov ; NCT05484544), RAPID-CPU ( www. CLINICALTRIALS: gov ; NCT03111862), ROMI ( www. CLINICALTRIALS: gov ; NCT01994577), SAMIE ( https://anzctr.org.au ; ACTRN12621000053820), SEIGE and SAFETY ( www. CLINICALTRIALS: gov ; NCT04772157), STOP-CP ( www. CLINICALTRIALS: gov ; NCT02984436), UTROPIA ( www. CLINICALTRIALS: gov ; NCT02060760).

Indexed as

Myocardial InfarctionTroponin IAngina PectorisBiomarkersClinical Studies as TopicHumansROC CurveTroponin TBiomarkersTroponin ITroponin TAcute myocardial infarctionBiomarkerMachine learningProbabilitySuper learnerTroponinValidation

Identifiers

PMID37131096
PMCPMC10449973
OpenAlexW4367675995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

and 3 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.